ARCHIVES

In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros”

This article is from The Cancer Letter archive.

Vol. 01 No. 42 | November 23, 1974

Download PDF Visit The Full Archive

Related Articles

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Cancer Meetings For May, June, Future

April 27, 1990

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006